Inhibition of BCR-ABL expression by DNA/RNA heteroduplex oligonucleotide

Toshimi Hoshiko

Presentation information

Oral Session

Oral Session 1-13C CML: Basic

Fri. Oct 12, 2018 3:10 PM - 4:10 PM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Kazuhito Naka (Department of Stem Cell Biology, Research Institute for Rediation Biology and Medicine, Hiroshima University, Japan)

[OS1-13C-6] Inhibition of BCR-ABL expression by DNA/RNA heteroduplex oligonucleotide

Toshimi Hoshiko¹, Yasushi Kubota^1,2, Satomi Nakagawara³, Takuya Akizawa³, Tatsuro Watanabe⁴, Kazuaki Tanigawara³, Jyunichi Yano³, Shinya Kimura^1,4 (1.Hematol & Oncol., Saga Univ., Saga, Japan, 2.Transfusion Med., Saga Univ Hosp., Saga, Japan, 3.Rena Therapeutics Inc., Tokyo, Japan, 4.Drug Discov. and Biomed. Sci., Saga Univ., Saga, Japan)

Abstract password authentication.
Password is written on a program and abstract book.